Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Dipeptidyl peptidase-4 inhibitors and risk of...
Journal article

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Abstract

OBJECTIVES: To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. DESIGN: Systematic review and meta-analysis of randomised and observational studies.

Authors

Li L; Li S; Deng K; Liu J; Vandvik PO; Zhao P; Zhang L; Shen J; Bala MM; Sohani ZN

Journal

The BMJ, Vol. 352, ,

Publisher

BMJ

DOI

10.1136/bmj.i610

ISSN

0959-8138